Magnesium in PDB 8wkg: Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis

Enzymatic activity of Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis

All present enzymatic activity of Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis:
3.1.4.35;

Protein crystallography data

The structure of Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis, PDB code: 8wkg was solved by F.C.Zhang, Y.Y.Huang, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 24.27 / 2.40
Space group P 31 2 1
Cell size a, b, c (Å), α, β, γ (°) 74.09, 74.09, 131.084, 90, 90, 120
R / Rfree (%) 18.6 / 23.5

Other elements in 8wkg:

The structure of Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis also contains other interesting chemical elements:

Chlorine (Cl) 1 atom
Zinc (Zn) 1 atom

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis (pdb code 8wkg). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis, PDB code: 8wkg:

Magnesium binding site 1 out of 1 in 8wkg

Go back to Magnesium Binding Sites List in 8wkg
Magnesium binding site 1 out of 1 in the Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg903

b:37.8
occ:1.00
 O A:HOH1033 2.0 35.3 1.0
OD1 A:ASP654 2.2 30.9 1.0
O A:HOH1028 2.2 30.4 1.0
O A:HOH1005 2.3 29.7 1.0
O A:HOH1009 2.3 29.6 1.0
O A:HOH1051 2.3 36.0 1.0
CG A:ASP654 3.2 36.5 1.0
OD2 A:ASP654 3.5 34.1 1.0
ZN A:ZN902 3.7 42.4 1.0
CD2 A:HIS653 4.0 29.8 1.0
OG1 A:THR723 4.0 29.2 1.0
O A:HIS653 4.0 34.5 1.0
OE2 A:GLU682 4.0 44.5 1.0
O A:WDB901 4.0 40.0 1.0
NE2 A:HIS685 4.1 34.4 1.0
CD2 A:HIS685 4.2 36.0 1.0
O A:THR723 4.5 40.6 1.0
CB A:ASP654 4.5 27.8 1.0
O A:HOH1105 4.5 56.7 1.0
CB A:THR723 4.5 31.5 1.0
NE2 A:HIS653 4.5 35.8 1.0
O2 A:WDB901 4.6 52.9 1.0
CD2 A:HIS657 4.6 31.2 1.0
OD2 A:ASP764 4.7 29.2 1.0
CA A:ASP654 4.7 30.6 1.0
C A:WDB901 4.7 31.8 1.0
O A:HOH1015 4.8 47.0 1.0
O A:HOH1090 4.8 53.6 1.0
C A:HIS653 4.9 29.1 1.0
CD A:GLU682 4.9 43.0 1.0
CG A:GLU682 4.9 41.3 1.0
NE2 A:HIS657 4.9 35.3 1.0

Reference:

F.C.Zhang, Y.Y.Huang, H.B.Luo, Y.N.Wu. Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis To Be Published.
Page generated: Thu Oct 31 22:19:08 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy